Results 1 to 10 of about 3,005,108 (342)
Biomedicines, 2023 Angiogenic factors (AF) promote vascular formation and may thus support neuroendocrine tumour (NET) development. This study aimed to assess AF serum level changes in NET patients treated with prolonged-acting somatostatin analogues (SSAs).
Violetta Rosiek +2 more
doaj +1 more source
Japanese Journal of Radiology, 2023 The pituitary gland is the body’s master gland of the endocrine glands. Although it is a small organ, many types of tumors can develop within it. The recently revised fifth edition of the World Health Organization (WHO) classifications (2021 World Health
Taro Tsukamoto, Yukio Miki
semanticscholar +1 more source
Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
The Journal of the National Comprehensive Cancer Network, 2021 The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Neuroendocrine and Adrenal Gland Tumors focus on the diagnosis, treatment, and management of patients with neuroendocrine tumors (NETs), adrenal tumors, pheochromocytomas ...
M. Shah +35 more
semanticscholar +1 more source
Biomedicines, 2023 The coronavirus disease-19 (COVID-19) pandemic dramatically impacted oncological patients’ care. Since the introduction of vaccines and the demonstration of their benefit on frail patients, COVID-19 vaccinations were indicated to also be beneficial to ...
Alice Laffi +12 more
doaj +1 more source
NETest: serial liquid biopsies in gastroenteropancreatic NET surveillance
Endocrine Connections, 2022 Objective: Up to now, serial NETest measurements in individuals assessing the disease course of gastroenteropancreatic neuroendocrine tumors (GEPNETs) at long-term follow-up and treatment response were not studied.
Mark J C van Treijen +4 more
doaj +1 more source
Risk of malignancy in adrenal tumors in patients with a history of cancer
Frontiers in Oncology, 2023 PurposeAdrenal gland is a common site of metastasis and on the other hand, metastases are the most frequent malignant adrenal tumors. The aim of this study was to estimate the risk of malignancy in suspicious adrenal mass in patients with a history of ...
Radosław Samsel +11 more
doaj +1 more source
BMC Gastroenterology, 2020 Background NETest, a novel multi-gene liquid biopsy has utility in neuroendocrine tumor (NET) diagnosis and identification of residual disease. We independently assessed utility of the NETest to diagnose gastric neuroendocrine neoplasms (GNENs) and ...
A. Malczewska +6 more
doaj +1 more source
Updates on medical treatment for neuroendocrine neoplasm [PDF]
Zhongguo aizheng zazhi, 2022 Neuroendocrine neoplasm (NEN) is a group of heterogeneous malignancies arising from neuroendocrine cells and peptidergic neurons. According to its cell differentiation, NEN can be divided into two distinct groups as well-differentiated neuroendocrine ...
LIANG Yun, JI Shunrong, YU Xianjun, CHEN Jie
doaj +1 more source
BMC Cancer, 2020 Background There are several treatment modalities for unresectable neuroendocrine tumors. Traditionally, the aim of these treatments has been to reduce the tumor load; referred to as objective response (OR).
Espen Thiis-Evensen +3 more
doaj +1 more source
Frontiers in Endocrinology, 2022 BackgroundTumor grade determined by the Ki67 index is the best prognostic factor for pancreatic neuroendocrine tumors (PanNETs). However, we often observe that the grade of metastases differs from that of their primary tumors.
Wu-Hu Zhang +60 more
doaj +1 more source